Elite Pharmaceuticals Inc (ELTP)
0.1356
+0.01
(+7.41%)
USD |
OTCM |
May 10, 15:59
Elite Pharmaceuticals Market Cap: 138.01M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 128.49M |
| May 08, 2024 | 134.35M |
| May 07, 2024 | 137.40M |
| May 06, 2024 | 146.05M |
| May 03, 2024 | 132.12M |
| May 02, 2024 | 131.48M |
| May 01, 2024 | 131.43M |
| April 30, 2024 | 132.00M |
| April 29, 2024 | 137.40M |
| April 26, 2024 | 134.86M |
| April 25, 2024 | 131.80M |
| April 24, 2024 | 128.55M |
| April 23, 2024 | 125.39M |
| April 22, 2024 | 129.46M |
| April 19, 2024 | 132.31M |
| April 18, 2024 | 135.87M |
| April 17, 2024 | 138.21M |
| April 16, 2024 | 137.65M |
| April 15, 2024 | 137.40M |
| April 12, 2024 | 142.49M |
| April 11, 2024 | 142.37M |
| April 10, 2024 | 143.20M |
| April 09, 2024 | 143.46M |
| April 08, 2024 | 141.22M |
| April 05, 2024 | 142.49M |
| Date | Value |
|---|---|
| April 04, 2024 | 140.25M |
| April 03, 2024 | 142.49M |
| April 02, 2024 | 155.72M |
| April 01, 2024 | 155.72M |
| March 28, 2024 | 157.08M |
| March 27, 2024 | 155.72M |
| March 26, 2024 | 155.06M |
| March 25, 2024 | 154.50M |
| March 22, 2024 | 153.89M |
| March 21, 2024 | 155.58M |
| March 20, 2024 | 151.65M |
| March 19, 2024 | 144.63M |
| March 18, 2024 | 146.56M |
| March 15, 2024 | 146.54M |
| March 14, 2024 | 141.47M |
| March 13, 2024 | 140.96M |
| March 12, 2024 | 136.38M |
| March 11, 2024 | 147.68M |
| March 08, 2024 | 154.70M |
| March 07, 2024 | 156.74M |
| March 06, 2024 | 158.63M |
| March 05, 2024 | 153.89M |
| March 04, 2024 | 161.85M |
| March 01, 2024 | 169.56M |
| February 29, 2024 | 167.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.90M
Minimum
Dec 29 2022
208.65M
Maximum
Jan 23 2024
63.56M
Average
53.60M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.420M |
| Palatin Technologies Inc | 36.63M |
| iBio Inc | 6.516M |
| Theriva Biologics Inc | 6.002M |
| Oragenics Inc | 8.245M |
Market Cap Related Metrics
| PE Ratio | 12.79 |
| PS Ratio | 2.918 |
| PEG Ratio | 0.1031 |
| Price to Book Value | 2.974 |
| Price | 0.1356 |
| Earnings Yield | 7.82% |
| PEGY Ratio | 0.1031 |
| Operating PE Ratio | 19.82 |
| Normalized PE Ratio | 10.03 |